Hypermethylation of RASSF1A Promoter Is Associated with the Age at Starting Smoking and a Poor Prognosis in Primary Non-Small Cell Lung Cancer

作者: Hojoong Kim , Jin Seuk Kim , Young Mog Shim , Yong-Ick Ji , Duk-Hwan Kim

DOI:

关键词: OncologyTobacco smokePathologyDNA methylationLung cancerCarcinomaHazard ratioMedicineSurvival analysisConfidence intervalRetrospective cohort studyInternal medicine

摘要: Cigarette smoking is the most common cause of lung cancer. The greatest risk cancer among those who started early in life and continued throughout their lives. However, molecular mechanisms responsible for susceptibility to young smoker are not clear. Recently, several groups have reported that hypermethylation CpG islands associated with exposure tobacco smoke. We studied association between age at starting p14, p16, RASSF1A promoters 204 primary non-small cell patients. also examined whether promoter an independent prognostic factor. Methylation rates samples were detected 9% 27% 32% RASSF1A. There was no relationship p14 p16 smoking. found be significantly (P = 0.001). No methylation status other variables, such as pack-years, status, duration patients earlier than without (19 +/- 8 versus 25 7; P Young smokers before 19 4.23 times [95% confidence interval (CI) 1.03-9.67; 0.001] more likely after 19. Furthermore, a poor prognosis stages 1 2 0.02 0.01, respectively; Log-rank test). hazard failure approximately 3.27 higher (95% CI 1.42-8.71; 0.01). habit had poorer (hazard ratio 2.14, 95% 1.22-9.11; 0.02). Our results suggest cigarette may factor

参考文章(20)
Reinhard Dammann, Chun Li, Jung-Hoon Yoon, Philip L. Chin, Steven Bates, Gerd P. Pfeifer, Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genetics. ,vol. 25, pp. 315- 319 ,(2000) , 10.1038/77083
Sara Milchgrub, John D. Minna, John W. Fondon, Adi F. Gazdar, Arvind K. Virmani, Gina Mele, Carmen Behrens, Farida Latif, Michael I. Lerman, Stephen Lam, Harold R. Garner, Bruce McKay, Luc Girard, Ignacio I. Wistuba, High Resolution Chromosome 3p Allelotyping of Human Lung Cancer and Preneoplastic/Preinvasive Bronchial Epithelium Reveals Multiple, Discontinuous Sites of 3p Allele Loss and Three Regions of Frequent Breakpoints Cancer Research. ,vol. 60, pp. 1949- 1960 ,(2000)
Gabriel Capella, Minoru Toyota, Manel Esteller, Stephen B. Baylin, Miguel Angel Peinado, James G. Herman, Silvia Tortola, Hypermethylation-associated Inactivation of p14ARF Is Independent of p16INK4a Methylation and p53 Mutational Status Cancer Research. ,vol. 60, pp. 129- 133 ,(2000)
Kwok-Wai Lo, Joseph Kwong, Angela Bik-Yu Hui, Sylvia Yat-Yee Chan, Ka-Fai To, Andrew Siu-Chung Chan, Lillian Shuk-Nga Chow, Peter ML Teo, Philip J Johnson, Dolly Poon Huang, None, High Frequency of Promoter Hypermethylation of RASSF1A in Nasopharyngeal Carcinoma Cancer Research. ,vol. 61, pp. 3877- 3881 ,(2001)
Setsuo Hirohashi, Koichi Kobayashi, Yae Kanai, Keisuke Eguchi, DNA Hypermethylation at the D17S5 Locus in Non-Small Cell Lung Cancers: Its Association with Smoking History Cancer Research. ,vol. 57, pp. 4913- 4915 ,(1997)
John D. Minna, Arafumi Maeshima, Ayaka Otsuka, Ryusei Saito, Tesshi Yamada, Toshiro Niki, Michiho Nishioka, Jun Yokota, Kimio Yoshimura, Takashi Kohno, Yoshio Tomizawa, Haruhiko Kondo, Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clinical Cancer Research. ,vol. 8, pp. 2362- 2368 ,(2002)
Christine A. Stidley, Frank D. Gilliland, William A. Palmisano, John F. Lechner, Steven A. Belinsky, Kevin K. Divine, Sally A. Winters, Richard E. Crowell, Marcie J. Grimes, Heidi J. Harms, Pam P. Moots, Carmen S. Tellez, Lida A. Crooks, Tammy M. Smith, Aberrant Promoter Methylation in Bronchial Epithelium and Sputum from Current and Former Smokers Cancer Research. ,vol. 62, pp. 2370- 2377 ,(2002)
Adrian Merlo, James G. Herman, Li Mao, Daniel J. Lee, Edward Gabrielson, Peter C. Burger, Stephen B. Baylin, David Sidransky, 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine. ,vol. 1, pp. 686- 692 ,(1995) , 10.1038/NM0795-686
J. G. Herman, J. R. Graff, S. Myohanen, B. D. Nelkin, S. B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 9821- 9826 ,(1996) , 10.1073/PNAS.93.18.9821
S. A. Belinsky, K. J. Nikula, S. B. Baylin, J. P. Issa, Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 4045- 4050 ,(1996) , 10.1073/PNAS.93.9.4045